logo
Ushering in a new dawn in obstetrics and gynecology: the industry of cell-free DNA testing
Prenatal exome sequencing for fetuses with structural abnormalities: the next step
Clinical implementation of cell-free DNA-based aneuploidy screening: perspectives from a national audit
Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis
Array comparative genomic hybridization and fetal congenital heart defects: a systematic review and meta-analysis
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks
First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing
A unified approach to risk assessment for fetal aneuploidies
Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy
Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies
UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake
Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies
Costs and benefits of non-invasive fetal RhD determination
Differentiation of genetic abnormalities in early pregnancy loss
Chromosomal microarray in fetuses with increased nuchal translucency
Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery
Maternal plasma cell-free DNA in the prediction of pre-eclampsia
Performance of non-invasive prenatal testing when fetal cell-free DNA is absent
Uptake of non-invasive prenatal testing by Japanese women
Prenatal diagnosis of androgen insensitivity syndrome using cell-free fetal DNA testing
Non-invasive prenatal testing – it's all a matter of timing
A flawed challenge but valid recommendation: a response to Takoudes and Hamar